Sort
30,917 grants matching “tumor microenvironment”
Engineered antibody fragments for PET imaging of immunotherapeutic targets in gliomas
$550,016Gary Kohanbash · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · CA
Systems analysis of cell-cell communication networks and immune activity in the melanoma tumor microenvironment
$549,997Kathryn Miller-Jensen · Yale University · U01 · FY2023 · CA
CAREER: Microbial control of intestinal organoids development and function
$549,995Abhinav Bhushan · Illinois Institute Of Technology · · FY2024 · ENG
Structure-function studies of LAG3 interactions with antibodies and cellular ligands
$549,962Vincent Christopher Luca · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2025 · CA
A Quantitative PET/CT Research Resource for Co-Clinical Imaging of Lung Cancer Therapies
$549,873Paul E Kinahan · University Of Washington · U24 · FY2024 · CA
Role of the CD44/Hyaluronan axis in mesenchymal prostate cancer
$549,768Maria Teresa Diaz Meco Conde · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · CA
Role of the CD44/Hyaluronan axis in mesenchymal prostate cancer
$549,768Maria Teresa Diaz Meco Conde · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · CA
Imaging and Targeting Metastatic-Prone Breast Cancer
$549,750Ronald G Blasberg · Sloan-Kettering Inst Can Research · R01 · FY2014 · CA
Delineating Functional Immunity via Image-Guided PET
$549,663Nerissa Therese Viola · Wayne State University · R37 · FY2019 · CA
PET Imaging of Cancer with pH (Low) Insertion Peptide (pHLIP)
$549,660Jason S Lewis · Sloan-Kettering Inst Can Research · R01 · FY2012 · CA
Rapid motion-robust quantitative DCE-MRI for the assessment of gynecologic cancers
$549,623Ricardo Otazo · Sloan-Kettering Inst Can Research · R01 · FY2024 · CA
Non-neoplastic cell types dictate gliomagenesis and
$549,607Dolores Hambardzumyan · Emory University · U01 · FY2016 · CA
Targeting Focal Adhesion Kinase to Improve RT-inducted Tumor Immunity
$549,598David G Denardo · Washington University · R01 · FY2023 · CA
Multiscale analysis of metabolic inflammation as a driver of breast cancer
$549,519Gerald V Denis · Boston University Medical Campus · U01 · FY2023 · CA
Regulation of Androgen Receptor by NXTAR Long non-coding RNA in Prostate Cancer and its Therapeutic Implications
$549,357Nupam P Mahajan · Washington University · R01 · FY2024 · CA
Role of circular RNA CDR1as in melanoma
$549,348Eva Hernando · New York University School Of Medicine · R01 · FY2020 · CA
Targeting adrenergic stress pathways to Increase tumor sensitivity to radiation and promote development of an anti-tumor immune response
$549,341Elizabeth Repasky · Roswell Park Cancer Institute Corp · R01 · FY2022 · CA
Targeting adrenergic stress pathways to Increase tumor sensitivity to radiation and promote development of an anti-tumor immune response
$549,341Elizabeth Repasky · Roswell Park Cancer Institute Corp · R01 · FY2023 · CA
Stromal Regulation of Basal Cell Carcinoma Formation
$549,316Anthony E Oro · Stanford University · R01 · FY2023 · AR
Elucidating the Immune Suppressive Mechanism of SIGLEC-15 in the Tumor Microenvironment
$549,292Jun Wang · New York University School Of Medicine · R01 · FY2024 · CA
Targeting Hypoxia-Induced Cancer-Cell Adaptation by Direct Inhibition of Akt and
$549,069Maurizio Pellecchia · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2012 · CA
Spatiotemporal modeling of cancer-niche interactions in breast cancer bone metastasis
$549,065Stephen Tc Wong · Methodist Hospital Research Institute · U01 · FY2020 · CA
Targeting Focal Adhesion Kinase to Improve RT-inducted Tumor Immunity
$549,025David G Denardo · Washington University · R01 · FY2021 · CA
Uncovering treatment targets for peripheral nerve sheath tumor progression in NF1
$548,991David Andrew Largaespada · University Of Minnesota · R01 · FY2024 · NS
Core C: Experimental Models
$548,945Michael E. Berens · Cleveland Clinic Lerner Com-Cwru · P01 · FY2022 · CA